During follicular growth, blood vessels that develop during follicular maturation in the theca cell layer do not penetrate the basement membrane \[[@r1]\]. The granulosa cell (GC) layer remains avascular until the breakdown of the basement membrane; thus, GCs are believed to develop under low oxygen (O~2~) tension or hypoxic conditions, as compared to atmospheric O~2~ tension \[[@r2],[@r3],[@r4]\]. Immediately after ovulation, the ruptured follicle is also thought to be under low oxygen tension due to bleeding and immature vascularization \[[@r5]\].

Cellular responses to hypoxic conditions are mediated by hypoxia-inducible factor 1 (HIF-1), an oxygen-regulated transcriptional activator \[[@r6]\]. HIF-1 is composed of two subunits: the oxygen-sensitive HIF-1α subunit and the constitutively expressed HIF-1β subunit \[[@r6], [@r7]\]. Under hypoxic conditions, the HIF-1α protein is stabilized and translocated from the cytoplasm to the nucleus, where it dimerizes with HIF-1β. This heterodimer then binds to a hypoxia response element (HRE) in target gene promoters and activates transcription of HIF-controlled genes involved in many physiological functions \[[@r6], [@r7]\]. There is increasing evidence that HIFs participate in ovulation and follicular differentiation. HIF-1α, induced by various stimuli, is suggested to serve as a key mediator of endothelin 2 expression, which performs a crucial function in ovulation in mammals \[[@r8]\]. In mice, HIFs control follicular rupture by regulating the expression of a specific subset of progesterone receptor (PGR)′s target genes, whereas blocking of HIF activity impairs ovulation \[[@r2]\]. Human chorionic gonadotropin (hCG) in synergy with hypoxic conditions has been demonstrated to up-regulate HIF-1α activity within luteinizing GCs both *in vivo* and *in vitro*; these findings suggest the fundamental roles for HIFs in follicle differentiation \[[@r9]\].

The protein level of HIF-1α increases in response to several stimuli, including hypoxia, proteasomal inhibitors, transition metals (Co^2+^, Mn^2+^, and Ni^2+^), iron chelators \[hydrophilic desferrioxamine (DFO) and lipophilic 2,2′-dipiridyl (DP)\] and other stressors \[[@r10],[@r11],[@r12]\]. Iron chelators and transition metals suppress the interaction between iron-mediated hydroxylation of HIF-1α and pVHL binding and inhibit hydroxylation of a key proline residue within the ODD domain of HIF-1α, thus resulting in accumulation of the HIF-1α protein \[[@r11]\]. Treatment with cobalt chloride (CoCl~2~) was found to mimic HIF-1 activation through inhibition of HIF-1α degradation. In latter process, HIF-1activation strongly induces vascular endothelial growth factor (VEGF), which represents the most important mechanism for hypoxia-induced angiogenesis in GCs of several species \[[@r12],[@r13],[@r14],[@r15],[@r16],[@r17]\]. On the other hand, HIF-1′s DNA-binding activity in the promoter region of target genes can be inhibited by echinomycin, a cyclic peptide that was originally discovered as a sequence-specific DNA-binding agent \[[@r18]\].

During the differentiation of GCs and theca cells into luteal cells, called the luteinization process, the main steroid product of ovaries (estrogen synthesized by follicles) is replaced by progesterone (P4) produced by the corpus luteum \[[@r19]\]. These changes are mediated by differentiation-dependent modification of the steroidogenic pathway. The key proteins and enzymes in P4 synthesis include steroidogenic acute regulatory protein (StAR; *STAR*), which transports cholesterol from the outer to inner mitochondrial membrane; cytochrome P450 side chain cleavage enzyme (P450scc; *CYP11A1*), which converts cholesterol into pregnenolone; and 3β-hydroxysteroid dehydrogenase (3β-HSD; *HSD3B*), which converts pregnenolone into P4 \[[@r20],[@r21],[@r22],[@r23],[@r24]\]. The rupture and collapse of a follicle at ovulation and the invasion by some elements, including theca cells and blood vessels, also commonly take place during luteinization \[[@r25]\].

Luteinization is thought to occur in a hypoxic environment. We previously suggested that hypoxia promotes P4 synthesis in our model of bovine luteinizing GCs \[[@r26]\]. Nevertheless, whether HIF-1 plays a role in hypoxia-driven enhancement of P4 synthesis during luteinization is not clear.

In the present study, we hypothesized that the hypoxia-induced increase in P4 synthesis during luteinization in bovine GCs is mediated by HIF-1. To test this hypothesis, we evaluated the effect of changes in the protein level of the α-subunit of HIF-1 by means of a hypoxia-mimetic compound (CoCl~2~) and by means of low-oxygen-tension culture with or without echinomycin in bovine cultured luteinizing and non-luteinizing GCs. We then quantified the P4 production as well as mRNA and protein expression of StAR, P450scc, and 3β-HSD in these cells.

Materials and Methods {#s1}
=====================

GC isolation and culture
------------------------

Bovine ovaries were obtained from a local slaughterhouse and were transported to the laboratory in ice-cold sterile physiological saline. The ovaries with healthy follicles were washed several times in sterile saline containing 100 IU/ml penicillin (Meiji Seika Pharma, Tokyo, Japan; 611400D3051) and 100 µg/ml streptomycin (Meiji Seika Pharma; 6161400D1034) as described previously \[[@r26]\]. GCs in follicular fluid were aspirated aseptically from healthy small follicles (≤ 6 mm in diameter) using a 2.5-ml disposable syringe and a 24-gauge needle, were pooled, then transferred to a plastic Petri dish filled with Dulbecco′s Modified Eagle′s Medium (DMEM) and Ham′s F-12 medium (1:1 \[v/v\]; Invitrogen, Carlsbad, CA, USA; 12400-024) containing 10% of calf serum (Invitrogen; 16170078), 20 μg/ml gentamicin (Sigma-Aldrich, St. Louis, MO, USA; G1397), 2 µg/ml amphotericin B (Sigma-Aldrich; A9528), and 50 IU heparin sodium salt (Nacalai Tesque, Kyoto, Japan; 17513-41). After removal of cumulus-oocyte complexes with a fine glass pipet under a dissecting microscope, GCs in follicular fluid were centrifuged (800 × *g*, 5 min at 4°C), then resuspended in Tris-HCl buffer (25 mM, pH 7.4) to rupture the blood cells after discarding the supernatant. The cell suspensions were centrifuged again and resuspended in DMEM (Sigma-Aldrich; D1152) supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin, and 0.1% of bovine serum albumin (BSA; Roche Diagnostics, Manheim, Germany; 10735086001) after the supernatant was discarded. This washing step was performed twice. The cell suspensions were then centrifuged, filtered through metal meshes (100 µm × 2, 80 µm × 2) to avoid cell aggregation, and were resuspended in a suitable volume of the culture medium (DMEM and Ham′s F-12 containing 10% of calf serum and 20 μg/ml gentamicin). The viability of GCs was assessed by a trypan blue dye exclusion assay.

The dispersed GCs were seeded at 0.5 × 10^5^ viable cells per 1 ml in the culture medium in 75-cm^2^ culture flasks (20 ml/flask; Greiner Bio-One, Frickenhausen, Germany; 658175) and cultured in a humidified atmosphere containing 5% CO~2~ at 37.5°C in a N~2~-O~2~-CO~2~-regulated incubator (ESPEC, Osaka, Japan; BNP-110) for 3--4 days. When the cultured cells reached 80--90% confluence, cell passaging was conducted using 0.1% bovine trypsin (Sigma-Aldrich; T92012) and sterile phosphate-buffered saline (PBS; Nissui Pharmaceutical, Tokyo, Japan; 05913). The GCs were seeded at the concentration of 2.0 × 10^5^ viable cells per 1 ml in 48-well cluster dishes (0.5 ml/well; Greiner Bio-One; 662160) for quantification of P4 production, in 96-well cluster dishes (0.1 ml/well; Iwaki, Chiba, Japan; 3860-096) for the cell viability assay, in 24-well cluster dishes (1.0 ml/well; Greiner Bio-One; 677180) for determination of gene expression, and in 75 cm^2^ culture flasks (20 ml/flask; Greiner Bio-One; 658175) for analysis of protein expression.

Preparation of luteinizing and non-luteinizing GCs and hypoxic culture conditions
---------------------------------------------------------------------------------

To prepare luteinizing and non-luteinizing GCs, the culture medium was replaced with a fresh medium containing 0.1% of BSA, 5 ng/ml sodium selenite (Sigma-Aldrich; S5261), 5 µg/ml transferrin (Sigma-Aldrich; T4132), and 0.5 mM ascorbic acid (Wako-Pure Chemical Industries Osaka, Japan; 031-12061), and the cells were then incubated in a normal culture atmosphere (20% O~2~, 5% CO~2~, and 75% N~2~) with or without insulin (2 µg/ml; Sigma-Aldrich; I4011) in the medium in combination with forskolin (10 µM; Research Biochemicals International, Natick, MA, USA; 70-0501-05) for 24 h. Insulin and insulin-like growth factor I (IGF-I) are known to stimulate proliferation of (and P4 production in) GCs \[[@r27],[@r28],[@r29],[@r30],[@r31]\]. In addition, forskolin increases intracellular cyclic AMP concentration via activation of adenylate cyclase \[[@r32]\]. Insulin in combination with forskolin mimics the effects of luteinizing hormone (LH) and activates adenylate cyclase via upregulation of P4 \[[@r33]\]. The concentration of insulin and forskolin was selected according to other reports \[[@r26], [@r34]\].

Experiment 1: Effects of CoCl~2~ on P4 production and cell viability
--------------------------------------------------------------------

To determine the effects of hypoxia, a hypoxia-mimicking agent (CoCl~2~; Sigma-Aldrich; C8661) was used. The luteinizing and non-luteinizing GCs were cultured in the presence or absence of CoCl~2~ (100 or 250 µM) for 2, 6, or 24 h. The conditioned media and the cultured cells were then collected to quantify P4 production by an enzyme immunoassay (EIA) and a spectrophotometric method. The cell viability after 24 h culture was also determined by Dojindo Cell Counting Kit including WST-1 (Dojindo, Kumamoto, Japan; 345-06463).

Experiment 2: Effects of CoCl~2~ on mRNA and protein expression levels of StAR, P450scc, and 3β-HSD
---------------------------------------------------------------------------------------------------

To measure the effect of CoCl~2~ on P4 synthesis, mRNA and protein expression levels of StAR, P450scc, and 3β-HSD were also evaluated. The luteinizing and non-luteinizing GCs were cultured in the presence or absence of CoCl~2~ (100 or 250 µM) for 2 or 6 h. The cells were then collected for real-time PCR and western blotting.

Experiment 3: The effect of CoCl~2~ on HIF-1α protein expression
----------------------------------------------------------------

Because HIF-1α expression is known to be strongly regulated by hypoxic conditions, we determined the effect of CoCl~2~ on HIF-1α protein expression. The luteinizing and non-luteinizing GCs were cultured in the presence or absence of CoCl~2~ (100 or 250 µM) for 2, 6, or 24 h. The cultured cells were then washed with PBS and harvested for western blotting.

Experiment 4: The effect of echinomycin on CoCl~2~-enhanced P4 synthesis
------------------------------------------------------------------------

To demonstrate the involvement of HIF-1α in CoCl~2~-enhanced P4 synthesis, echinomycin (Sigma-Aldrich; SML0477), a small-molecule inhibitor of HIF-1 activity, was used. The luteinizing and non-luteinizing GCs were exposed to CoCl~2~ (100 µM) in the presence or absence of echinomycin for 2 or 6 h. P4 production and mRNA and protein expression levels of *STAR*, *P450scc*, and *3β-HSD* were then quantified.

Experiment 5: The effect of echinomycin on 10% O~2~-enhanced P4 synthesis
-------------------------------------------------------------------------

In our previous study, we found that 10% O~2~ increases P4 synthesis \[[@r26]\]. To determine the role of HIF-1 in 10% O~2~-enhanced P4 synthesis, echinomycin --- a small molecule inhibitor of HIF-1 activity \[[@r18]\] --- was added to the culture medium of luteinizing and non-luteinizing GCs incubated at 10% O~2~ for 24 h. P4 production and the mRNA and protein expression levels of STAR, P450scc, and 3β-HSD were then measured.

Quantification of P4 production
-------------------------------

To measure P4 production, EIA and DNA assay were performed. The conditioned media were collected and stored at --30°C until analysis of P4 concentration. This concentration was determined by EIA as described previously \[[@r35]\]. The standard curve had a range from 0.391 to 100 ng/ml. To fit the range of concentrations of the standards, the culture media were diluted 1:10. The cultured cells were also stored at --30°C until the DNA content was measured by spectrophotometry as described previously \[[@r36]\] and was used to normalize the P4 concentrations. Four experiments were conducted, and each treatment was tested in triplicate wells in each experiment. Neither CoCl~2~ nor 10% O~2~ altered the cell number (data not shown).

RNA isolation, cDNA synthesis, and real-time PCR
------------------------------------------------

Total RNA was extracted to determine mRNA expression of *STAR*, *CYP11A1*, and *HSD3B*. For this purpose, we used TRIsure (Bioline, London, UK; BIO-38033). The extracted RNA from each sample was quantified using a NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The total RNA was reverse-transcribed on a ThermoScript RT-PCR system (Invitrogen; 11146-016).

*STAR, CYP11A1*, and *HSD3B* mRNA expression levels were measured by real-time PCR using the MyiQ (Bio-Rad, Tokyo, Japan) and the iQ SYBR Green supermix (Bio-Rad; 170-8880) starting with 1 ng of reverse-transcribed total RNA as described previously \[[@r37]\]. Standard curves of sample cDNA were generated using serial dilutions (1:2 to 1:1,000). Expression of the 18S ribosomal RNA gene (*18SrRNA*) served as an internal control. In a preliminary experiment, *18SrRNA* was confirmed to not be influenced by luteinization and hypoxia (data not shown). Twenty-base pair primers with 50--60% GC content were synthesized for PCR ([Table 1](#tbl_001){ref-type="table"}Table 1.Primers used in real-time PCRGenePrimerSequence (5\'--3\')Accession no.Product (bp)*STAR*ForwardCCCATGGAGAGGCTTTATGAY17259115ReverseTGATGACCGTGTCTTTTCCA*CYP11A1*ForwardCTGGCATCTCCACAAAGACCJ05245131ReverseGTTCTCGATGTGGCGAAAGT*HSD3B*ForwardCCAAGCAGAAAACCAAGGAGX17614109ReverseATGTCCACGTTCCCATCATT*18SrRNA*ForwardTCGCGGAAGGATTTAAAGTGAY779625141ReverseAAACGGCTACCACATCCAAG).

The PCR conditions were as follows: 95°C for 30 sec, followed by 45 cycles of 94°C for 6 sec, 60°C for 30 sec, and 65°C for 6 sec. The use of the QuantiTect SYBR Green PCR system at elevated temperatures resulted in reliable and sensitive quantification of the PCR products, with high linearity. The melting curve analysis was used to confirm that only the target amplicon was amplified.

Western blotting
----------------

The cells were washed with ice-cold PBS, scraped from the culture flask in 1 ml of ice-cold homogenization buffer (25 mM Tris-HCl pH 7.4, 300 mM sucrose, 2 mM EDTA, and Complete \[protease inhibitor cocktail; Roche Diagnostics; 11697498001\]). The cell suspension was centrifuged at 19,000 × *g* for 30 min, the supernatant was discarded, and the pellet was lysed in 100 µl of lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% of Triton X-100, 10% of glycerol \[Sigma; G7757\], and Complete). The protein samples were then stored at --80°C until protein expression of HIF-1α, StAR, P450scc, and 3β-HSD was analyzed by western blotting.

The protein concentration was determined by the method described elsewhere \[[@r38]\], using BSA as a standard. The protein samples were solubilized in SDS gel-loading buffer (50 mM Tris-HCl pH 6.8, 2% of SDS \[Nacalai Tesque; 31607-94\], 10% of glycerol, and 1% of β-mercaptoethanol \[Wako Pure Chemical Industries; 137-06862\]) and heated at 95°C for 10 min. Next, the samples (50 µg protein) were subjected to SDS-PAGE in a 7.5% gel with pre-stained molecular weight markers (Bio-Rad; 161-0374) for 1 h at 200 V.

The separated proteins were electrophoretically transblotted to a PVDF membrane (GE Healthcare, Limited, Buckinghamshire, UK; RPN1416LFP) for 1 h at 25 V in transfer buffer (25 mM Tris-HCl, 192 mM glycine, and 20% of methanol). The membrane was washed in TBS-T (0.1% of Tween 20 in TBS \[25 mM Tris-HCl, 137 mM NaCl, pH 7.5\]) for 10 min and was incubated in PVDF blocking buffer (Toyobo, Osaka, Japan; NYBR01) for 1 h at room temperature. The membranes were then incubated separately with a primary antibody in an immunoreaction enhancer solution (Toyobo; NKB-101) specific to each protein: an anti-HIF-1α antibody (Sigma-Aldrich; SAB2104366; 1:500), anti-StAR antibody (Abcam; ab96637; 1:3,000); anti-P450scc antibody (Abcam; ab75497; 1:1,000), anti-3β-HSD antibody (Abcam; ab75710; 1:3,000), and an anti-β-actin antibody (ACTB; Sigma-Aldrich; A2228; 1:8,000) overnight at 4°C. The membranes were washed three times for 5 min in TBS-T at room temperature, incubated with a secondary antibody in the immunoreaction enhancer solution (for HIF-1α, StAR, and P450scc \[1:5,000 dilution\]: an anti-rabbit IgG horseradish peroxidase \[HRP\]-conjugated whole antibody produced in donkey; Amersham Biosciences, Piscataway, NJ; NA934; 3β-HSD and ACTB \[1:40,000\]: an anti-mouse IgG HRP-conjugated whole antibody produced in sheep; Amersham Biosciences; NA931) for 1 h and were washed three times in TBS-T 5 min each at room temperature. The signals were detected by means of the ECL Western Blotting Detection System (Amersham Biosciences; RPN2109). The intensity of the immunological reaction (HIF-1α, StAR, P450scc, 3β-HSD, and ACTB) in the cells was estimated by measuring optical density of a defined area by computerized densitometry in the NIH Image software (National Institutes of Health, Bethesda, MD, USA).

The WST-1 assay
---------------

WST-1, a version of MTT (3-\[4,5-dimethyl-2 thiazolyl\]-2,5-diphenyl-2 H-tetrazolium bromide), is a yellow tetrazolium salt that is reduced to formazan by viable cells containing active mitochondria. The culture medium was replaced with 100 μl of the D/F medium with BSA without phenol red, and a 10-μl aliquot of the assay reagent (0.3% WST-1, 0.2 mM 1-methoxy phenazine methosulfate in PBS, pH 7.4) was added to each well. The cells were then incubated for 4 h at 38°C. The absorbance was read at 450 nm using a microplate reader (Model 450; Bio-Rad Laboratories). The measured absorbance directly correlates with the number of viable cells \[[@r39]\]. In this assay, data were expressed as a percentage of the appropriate control values.

Statistical analyses
--------------------

All data are shown as mean ± SEM. The statistical analyses were performed in the GraphPad Prism 4 software. Statistical significance of differences in all experiments was assessed by one-way analysis of variance (ANOVA) followed by Fisher′s protected least-significant difference procedure as a multiple-comparison test for each group: the group of non-luteinizing GCs and the group of luteinizing GCs. Differences with P \< 0.05 were considered statistically significant.

Results {#s2}
=======

P4 production by luteinizing and non-luteinizing GCs
----------------------------------------------------

Insulin increased P4 production by GCs cultured for 24 h under 20% O~2~ ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Effects of CoCl~2~ on P4 production by luteinizing and non-luteinizing GCs and on cell viability. To prepare luteinizing and non-luteinizing GCs, we cultured the cells at 20% O~2~ in the presence of insulin (2 µg/ml) and/or forskolin (10 µM) for 24 h. P4 production was then quantified (A). To measure P4 production, the culture media were collected for an enzyme immunoassay (EIA) of P4, while the cultured cells were collected for measurement of DNA content by spectrophotometry to normalize the P4 concentration. The cells cultured without insulin and forskolin were defined as non-luteinizing GCs, while the cells cultured in the presence of insulin in combination with forskolin were defined as luteinizing GCs (control: non-luteinizing GCs, insulin + forskolin: luteinizing GCs). After 24 h, the luteinizing and non-luteinizing GCs were cultured with or without CoCl~2~ (100 or 250 µM) for 2 (B), 6 (C), or 24 h (D) to determine the effect of CoCl~2~ on P4 production. P4 production value was shown as a percentage of control (cultured non-luteinizing GCs without CoCl~2~). (E) The effect of CoCl~2~ on cell viability was also determined. The cultured cells were incubated with the WST-1 reagent for 4 h at 38°C, then the absorbance was read using a microplate reader. The data are shown as a percentage of control (cultured cells without CoCl~2~) for each group: the group of luteinizing GCs and the group of non-luteinizing GCs. Different letters (A) and asterisks (B, C) indicate significant differences (P \< 0.05) between groups as determined by one-way ANOVA. All data represent mean ± SEM of four independent experiments.; P \< 0.05). GCs cultured with insulin in combination with forskolin produced more P4. According to these results, the treated and untreated GCs were used as a model of luteinizing and non-luteinizing GCs in further experiments.

Effects of CoCl~2~ on P4 production and cell viability
------------------------------------------------------

To characterize the effects of hypoxia and HIF-1α, we cultured luteinizing and non-luteinizing GCs with 100 or 250 µM CoCl~2~ for 2, 6, or 24 h. After 2 and 6 h of culture, 100 and 250 µM CoCl~2~ increased P4 production by luteinizing GCs, but these treatments did not have any effect on P4 production by non-luteinizing GCs ([Fig. 1B and 1C](#fig_001){ref-type="fig"}). On the other hand, after 24 h of culture, 100 and 250 µM CoCl~2~ tended to decrease P4 production by luteinizing GCs ([Fig. 1D](#fig_001){ref-type="fig"}). CoCl~2~ did not affect cell viability within 24 h after CoCl~2~ addition, meaning that CoCl~2~ under these conditions did not cause cell toxicity in this study ([Fig. 1E](#fig_001){ref-type="fig"}).

Effects of CoCl~2~ on mRNA and protein expression levels of StAR, P450scc, and 3β-HSD
-------------------------------------------------------------------------------------

To determine the effects of hypoxia and HIF-1 on P4 synthesis, we also analyzed the expression of key steroidogenic factors involved in P4 synthesis: StAR, P450scc, and 3β-HSD. The real-time PCR analysis showed that 100 µM CoCl~2~ after 6 h significantly increased *STAR* mRNA expression in luteinizing GCs ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Effects of CoCl~2~ on the expression levels of StAR, P450scc, and 3β-HSD in non-luteinizing and luteinizing GCs. These cells were incubated with or without CoCl~2~ (100 or 250 µM) for 2 or 6 h. Total RNA was then extracted from harvested cells to determine mRNA expression of *STAR* (A) by real-time PCR. The amount of *STAR* mRNA is expressed relative to the amount of *18SrRNA* mRNA. The protein expression levels of StAR (B), P450scc (C), and 3β-HSD (D) were determined by western blotting. All the protein expression levels are expressed relative to the level of β-actin protein expression. The blot was incubated with primary antibodies against StAR, P450scc, 3β-HSD, or β-actin and then incubated with a secondary antibody conjugated with HRP. The resultant signal was detected by chemiluminescence and quantitated by computer-assisted densitometry. Asterisks indicate significant differences (P \< 0.05) between groups --- the group of luteinizing GCs and the group of non-luteinizing GCs --- as determined by one-way ANOVA. All data represent mean ± SEM of four independent experiments.; P \< 0.05) but did not affect *CYP11A1* and *HSD3B* mRNA expression levels (data not shown).

Western blotting analyses revealed that 100 µM CoCl~2~ after 2 and 6 h significantly increased StAR protein expression in luteinizing GCs ([Fig. 2B](#fig_002){ref-type="fig"}; P \< 0.05) but did not affect CYP11A1 and HSD3B protein expression ([Fig. 2C and 2D](#fig_002){ref-type="fig"}).

The effect of CoCl~2~ on HIF-1α protein expression
--------------------------------------------------

After 2 and 6 h of culture in the presence of 100 µM CoCl~2~, we observed the highest expression of the HIF-1α protein concomitant with an increase in StAR protein expression ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Effects of CoCl~2~ on HIF-1α and StAR protein expression levels. The luteinizing and non-luteinizing GCs were incubated with or without CoCl~2~ (100 or 250 µM) for 2 h or 6 h. The cells were then collected to determine HIF-1α and StAR protein expression by western blotting. The blot was incubated with primary antibodies against HIF-1α, StAR, or β-actin and then with a secondary antibody conjugated with HRP. The resultant signals were detected by chemiluminescence and quantitated by computer-assisted densitometry.). Although the expression of HIF-1α was detectable, there was no significant difference between the presence and the absence of 100 µM CoCl~2~ in culture. Based on these results, we chose 100 µM CoCl~2~ for 2 and 6 h as the conditions mimicking hypoxia in all subsequent experiments.

The effect of echinomycin on CoCl~2~-enhanced P4 synthesis
----------------------------------------------------------

0.5 nM echinomycin inhibited P4 production ([Fig. 4A](#fig_004){ref-type="fig"}Fig. 4.The effect of echinomycin (Ech) on CoCl~2~-enhanced P4 synthesis. The luteinizing and non-luteinizing GCs were cultured with or without 0.5 nM echinomycin in the presence of 100 μM CoCl~2~ for 2 or 6 h. To determine P4 production, the culture media were collected for EIA to measure P4 concentration, while the cultured cells were collected for analysis of DNA content by a spectrophotometric method to normalize the P4 concentrations. P4 amounts are shown as a percentage of the control (cultured non-luteinizing GCs without CoCl~2~) (A). *STAR* mRNA expression was determined by real-time PCR (B). The amount of *STAR* mRNA is expressed relative to the amount of *18SrRNA* mRNA. The protein expression of StAR was determined by western blotting (C). The protein level is expressed relative to the protein expression of β-actin. Asterisks indicate significant differences (P \< 0.05) between groups --- the group of luteinizing GCs and the group of non-luteinizing GCs --- as determined by one-way ANOVA. All data represent mean ± SEM of four independent experiments. Representative examples of western blotting for StAR and β-actin are shown in (D).; P \< 0.05) and the expression of STAR mRNA ([Fig. 4B](#fig_004){ref-type="fig"}; P \< 0.05) and protein ([Fig. 4C and 4D](#fig_004){ref-type="fig"}; P \< 0.05) under hypoxic conditions induced by CoCl~2~ (incubation for 2 or 6 h) in luteinizing GCs.

The effect of echinomycin on 10% O~2~-enhanced P4 synthesis
-----------------------------------------------------------

We also evaluated the involvement of HIF-1 in 10% O~2~-enhanced P4 synthesis by means of echinomycin. In agreement with our previous findings \[[@r26]\], culturing of luteinizing GCs under 10% O~2~ significantly increased P4 production after 24 h ([Fig. 5A](#fig_005){ref-type="fig"}Fig. 5.The effect of echinomycin (Ech) on 10% O~2~-enhanced P4 synthesis. The luteinizing and non-luteinizing GCs were cultured at 20% O~2~ as a control or at 10% O~2~ as low-oxygen tension for 2, 6, or 24 h to quantify P4 production (A). To this end, the culture media were collected for EIA of P4, while the cultured cells were collected for measurement of DNA content by a spectrophotometric method to normalize the P4 concentrations. Other batches of luteinizing and non-luteinizing GCs were cultured at 20% or 10% O~2~ with or without 0.5 nM echinomycin for 24 h, then P4 production was measured (B). P4 amounts are shown as a percentage of the control (cultured non-luteinizing GCs cells at 20% O~2~ without echinomycin). *STAR* mRNA expression was quantified by real-time PCR (C), and StAR protein expression was determined by western blotting (D). Asterisks indicate significant differences (P \< 0.05) between groups --- the group of luteinizing GCs and the group of non-luteinizing GCs --- as determined by one-way ANOVA. All data represent mean ± SEM of four independent experiments. Representative examples of western blotting for StAR and β-actin are shown in (E).; P \< 0.05). Culturing of luteinizing GCs under 10% O~2~ also increased the expression of STAR mRNA ([Fig. 5C](#fig_005){ref-type="fig"}; P \< 0.05) and protein ([Fig. 5D and 5E](#fig_005){ref-type="fig"}; P \< 0.05) in comparison with cultivation under 20% O~2~. Echinomycin attenuated the 10% O~2~ effects that increased P4 production ([Fig. 5B](#fig_005){ref-type="fig"}; P \< 0.05) and the increased expression of STAR mRNA ([Fig. 5C](#fig_005){ref-type="fig"}; P \< 0.05) and protein ([Fig. 5D and 5E](#fig_005){ref-type="fig"}; P \< 0.05) after 24 h in luteinizing GCs.

Discussion {#s3}
==========

LH pulses increase gradually and result in an LH surge. The increasing LH pulses stimulate dominant follicle growth, ovulation, and luteinization \[[@r40], [@r41]\]. In the follicle compartment before ovulation, GCs and the oocyte develop in an avascular environment that is considered to be hypoxic \[[@r2],[@r3],[@r4]\]. The microenvironment of the ruptured follicle is also thought to be hypoxic immediately after ovulation \[[@r5]\]. Thus, luteinization and hypoxia seem to occur simultaneously the time of ovulation. Luteinization is defined as the process in which GCs and theca cells differentiate into luteal cells and then produce a large amount of P4, which is important for establishing pregnancy \[[@r10], [@r42],[@r43],[@r44]\]. We previously suggested that hypoxic conditions promote the progression and completion of luteinization by enhancing P4 synthesis in bovine GCs \[[@r26]\]. Using the same model of bovine cultured luteinizing GCs, we found in the present study that enhancement of P4 synthesis either by hypoxia (10% O~2~) or by CoCl~2~ is attenuated by the addition of echinomycin, the inhibitor of HIF-1 DNA binding \[[@r18]\], suggesting that HIF-1-mediated P4 upregulation takes place during luteinization. The present results strongly support the idea that hypoxic conditions are important for luteinization and for steroidogenesis during this period.

In the present study, we used CoCl~2~ to mimic hypoxia because treatment with this compound has been shown to successfully mimic hypoxia in other studies \[[@r8], [@r20], [@r45]\]. CoCl~2~ (100 and 250 µM) increased P4 production after 2 and 6 h in luteinizing GCs. Concentrations of CoCl~2~ up to 500 µM have been used in some studies on HIF-1α \[[@r46], [@r47]\]. Simultaneously with the increase in P4 production, 100 µM CoCl~2~ can also sufficient to increase the HIF-1α protein level after 2 and 6 h. In addition, the present results indicated that CoCl~2~ has the same effects as 10% O~2~ does on HIF-1α protein expression and on P4 production in luteinizing GCs, as shown in our previous study \[[@r26]\]. This low-oxygen condition may represent the O~2~ condition in the cells during luteinization. This finding suggests that low-oxygen conditions promote P4 production during rather than before luteinization.

Our results showed that treatment of luteinizing GCs with CoCl~2~ for 24 h tended to decrease their P4 production. Similarly, 500 µM CoCl~2~ and 1% O~2~ for 24 h inhibited P4 synthesis in bovine luteinized GCs obtained from the largest follicle \[[@r48]\]. Hypoxia seems to have a biphasic effect on steroidogenesis depending on oxygen tension and on duration of exposure to hypoxia. The induction of apoptosis by hypoxia was found to be most pronounced after exposure of normal cells or tissues to severe hypoxia \[[@r49], [@r50]\]. Hypoxia-mimicking agents, such as CoCl~2~, and low oxygen tension are also known to induce apoptosis in a number of cell types \[[@r49]\]. Nevertheless, the degrees of apoptosis in the GCs exposed to CoCl~2~ or to low oxygen tension was not assessed in the present study, and further studies would be required to address this issue.

StAR is one of the key proteins in P4 synthesis. In GCs, StAR expression signals early functional maturation of an ovarian antral follicle \[[@r51]\]. During luteinization, StAR expression is upregulated in order to transfer cholesterol from the outer to inner mitochondrial membrane \[[@r11], [@r52],[@r53],[@r54],[@r55],[@r56]\]. We confirmed that luteinizing GCs in our present model show higher expression of StAR in comparison with non-luteinizing GCs as shown in our previous study \[[@r26]\]. In luteinizing GCs, expression of the StAR protein is increased by 100 µM CoCl~2~ after 2 or 6 h of incubation and by 10% O~2~ after 24 h. The observed exposure duration necessary for CoCl~2~ or 10% O~2~ to increase StAR expression in luteinizing GCs is in agreement with their exposure time necessary to increase P4 production. One of the reasons why CoCl~2~ increased P4 production ([Fig. 1B and 1C](#fig_001){ref-type="fig"}) together with mRNA ([Fig. 2A](#fig_002){ref-type="fig"}) and protein expression of StAR ([Fig. 2B](#fig_002){ref-type="fig"}) during shorter culture periods (2 and 6 h) than 10% O~2~ did (24 h; [Fig. 5A--E](#fig_005){ref-type="fig"}) is that the direct inhibition of HIF-1α protein degradation by CoCl~2~ \[[@r20]\] is more effective than the influence of 10% O~2~ on HIF-1α protein accumulation. On the other hand, neither CoCl~2~ nor 10% O~2~ affected P450scc and 3β-HSD expression levels. These results suggest that hypoxic conditions promote P4 production via the upregulation of StAR during luteinization.

Echinomycin is a DNA-binding agent that binds to the HRE site within the promoters of HIF-1′s target genes and selectively inhibits the binding activity of HIF-1α \[[@r18]\]. In rats undergoing gonadotropin-induced ovulation, blockage of HIF-1 activity by echinomycin profoundly impairs the rupture of preovulatory follicles and reduces VEGF expression \[[@r2]\], suggesting that HIF-1 performs important functions in ovulation, especially in steroidogenesis during luteinization. Our finding in the present study that echinomycin attenuated hypoxia-enhanced P4 production and StAR expression in luteinizing GCs suggests that the increase in P4 synthesis during luteinization is stimulated by the transcription-regulatory activity of HIF-1. All these results may explain additional roles of hypoxia and HIF-1 around approximately at the time of ovulation, especially steroidogenesis, which is required not only for ovulation but also for luteinization.

In our previous studies \[[@r57], [@r58]\], we reported that hypoxia also affects luteolysis. Hypoxia has been shown to induce corpus luteum regression and to promote apoptosis of luteal cells, in which an oxygen deficiency or low-oxygen conditions suppress P4 production. It seems that hypoxia has a biphasic effect on P4 production during luteinization and in luteolysis depending on the differentiation status of the cells. The cells used in the present study were early-growing luteal cells, which start producing a large amount of P4, whereas the cells analyzed in our previous study were luteal cells obtained from a mid-stage corpus luteum, which produce the largest amount of P4.

In agreement with our present results, it has been reported that 10% O~2~ stimulates *STAR* gene transcription in immortalized (KK1) murine GCs, and that HIF-1α seems to be actively involved in direct regulation of basal and dibutyryl cyclic AMP-stimulated StAR protein expression by binding to the proximal murine *STAR* promoter \[[@r59]\]. Further studies are needed to explain why hypoxic conditions and HIF-1 affected P4 synthesis in luteinizing GCs but not in non-luteinizing GCs in the present study. In conclusion, overall, our findings suggest that the hypoxia-induced increase in P4 production and in StAR expression in bovine cultured luteinizing GCs is mediated by HIF-1. In other words, by enhancing P4 synthesis, HIF-1 may play as an important factor in the progression of luteinization by enhancing P4 synthesis.
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